RAPid SimPLE Targeted Radiation Treatment for Brain Metastases

The aim of the study is to show that rapid, simple targeted radiotherapy to brain metastases with 8 Gy / 1 is non-inferior to 20 Gy / 5 in terms of overall survival for patients with poor prognosis.

Trial Details

NCT ID
NCT05050929
Phase
PHASE2
Sponsor
British Columbia Cancer Agency
Status
RECRUITING
Cancer Type
Brain Cancer
Interventions
  • Targeting All Brain Metastases
Locations (sample)
  • Abbotsford British Columbia, British Columbia, Canada|49.05798,-122.25257
  • Kelowna, British Columbia, Canada|49.88307,-119.48568
  • Prince George, British Columbia, Canada|53.9166,-122.75301
  • Surrey, British Columbia, Canada|49.10635,-122.82509
  • Vancouver, British Columbia, Canada|49.24966,-123.11934

Key Eligibility Criteria

  • Subjects must meet all of the following criteria to be eligible for participation in this study:
  • Pathological diagnosis of a non-hematopoietic malignancy
  • Brain metastases of any size
  • Any number of untreated or progressing, previously treated brain metastases that can all be contoured and targeted

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Brain Cancer Trials on Trialify →